Marco Sorio
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.
Journal: Blood cell therapy
Published: January 27, 2024
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies.
Journal: Leukemia & lymphoma
Published: January 02, 2024
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Journal: Hematological oncology
Published: August 31, 2021
Treatment of very high-risk classical Hodgkin Lymphoma: cases' selection from real life and critical review of the literature.
Journal: Acta bio-medica : Atenei Parmensis
Published: May 25, 2020
Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation.
Journal: Journal of blood medicine
Published: July 22, 2019
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
Published: November 30, 2018
Brentuximab vedotin: axonal microtubule's Apollyon.
Journal: Blood cancer journal
Published: August 29, 2015
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series.
Journal: Leukemia & lymphoma
Published: October 06, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026